1-9 of 9
Karima Yacouben
Close
Sort by
Journal Articles

Molecular Responses At 3 Months Are Associated With a Better Subsequent Molecular response and Outcome In Children and Adolescents With CML In Chronic Phase: Results Of a Retrospective Analysis From The French Glivec Phase 4 Study

Frédéric Millot, Joelle Guilhot, PhD, André Baruchel, MD, Arnaud Petit, MD, Thierry Leblanc, MD, Yves Bertrand, Françoise Mazingue, Patrick Lutz, Cécile Vérité, MD, Christian Berthou, MD, Claire Galambrun, MD, Nicolas Sirvent, Karima Yacouben, Pascal Chastagner, Virginie Gandemer, MD, PhD, Yves Reguerre, MD, Gérard Couillaud, MD, Jean-Michel Cayuela
Journal: Blood
Blood (2013) 122 (21): 2730.
https://doi.org/10.1182/blood.V122.21.2730.2730
Published: 2013
Journal Articles

Imatinib Has a Negative Impact On Growth In Children With Previously Untreated Chronic Myeloid Leukaemia (CML) In Early Chronic Phase (CP): Results Of The French National Study

Frédéric Millot, Joelle Guilhot, Ph.D., Andre Baruchel, MD, PhD, Arnaud Petit, MD, Thierry Leblanc, MD, Yves Bertrand, Françoise Mazingue, Patrick Lutz, Cécile Vérité, Christian Berthou, Claire Galambrun, Nicolas Sirvent, Karima Yacouben, Pascal Chastagner, Virginie Gandemer, MD, PhD, Yves Reguerre, Gérard Couillaud, Jean-Michel Cayuela
Journal: Blood
Blood (2013) 122 (21): 4001.
https://doi.org/10.1182/blood.V122.21.4001.4001
Published: 2013
Journal Articles

The Prognosis of Children Acute Lymphoblastic Leukemia (ALL) with Minimal Residual Disease (MRD) ≥10-2 After Induction (TP1) Depends on the Prephase Response and on the Level of the MRD After Consolidation (TP2): Results of the 58951EORTC Trial

Yves Bertrand, Stefan Suciu, Nathalie Grardel, Marleen Bakkus, PhD, Francoise Mazingue, MD, Karima Yacouben, Anne Uyttebroeck, Patrick Lutz, Dominique Plantaz, Sandrine Girard, Nicole Dastugue, Yves Benoit, MD, Hélène Cavé
Journal: Blood
Blood (2011) 118 (21): 2571.
https://doi.org/10.1182/blood.V118.21.2571.2571
Published: 2011
Journal Articles

Related Myeloablative Stem Cell Transplantation (SCT) to Cure Sickle Cell Anemia (SCA): Update of French Results

Francoise Bernaudin, Marie Robin, Christèle Ferry, Karima Yacouben, Jean-Hugues Dalle, Régis Peffault de Latour, Yves Bertrand, Corinne Pondarre, Mathieu Kuentz, Jean-Pierre Vannier, Alain Fischer, Isabelle Thuret, Patrick Lutz, Pierre Bordigoni, Pierre Rohrlich, Jean-Louis Stephan, Nathalie Dhedin, Jean Paul Vernant, Jean-Yves Cahn, Francois Demeocq, Bernard Rio, Dominique Bories, Eliane Gluckman, Gérard Socié
Journal: Blood
Blood (2010) 116 (21): 3518.
https://doi.org/10.1182/blood.V116.21.3518.3518
Published: 2010
Journal Articles

Imatinib Is Efficient but Has a Negative Impact On Growth in Children with Previously Untreated chronic Myelogenous Leukaemia (CML) in Early Chronic Phase (CP): Results of the French National Phase IV Trial.

Frédéric Millot, MD, Andre Baruchel, MD, Joelle Guilhot, BS, Arnaud Petit, MD, Thierry Leblanc, MD, Yves Bertrand, MD, Françoise Mazingue, Lutz Patrick, MD, Cécile Vérité, MD, Christian Berthoux, MD, Claire Galambrun, MD, Frédéric Bernard, MD, Karima Yacouben, MD, Pierre Bordigoni, Pr, Christine Edan, MD, Yves Reguerre, MD, Gérard Couillaud, MD, Jean-Michel Cayuela, MD, François Guilhot, MD
Journal: Blood
Blood (2009) 114 (22): 863.
https://doi.org/10.1182/blood.V114.22.863.863
Published: 2009
Journal Articles

Prognostic Significance of Central Nervous System (CNS) Status of Children with Acute Lymphoblastic Leukemia (ALL) Treated without Cranial Irradiation: Results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group Study 58951

Nicolas Sirvent, Stefan Suciu, Yves Benoit, Yves Bertrand, Brigitte Nelken, Alain Robert, Anne Uyttebroeck, Patrick Lutz, MD, Alina Ferster, MD, PhD, Karima Yacouben, Lucilia Norton, Geneviève Margueritte, Martine Munzer, Dominique Plantaz, Frédéric Millot, Patrick Boutard, Pierre Philippet, Claire Hoyoux, Liliana Baila, Jacques Otten
Journal: Blood
Blood (2008) 112 (11): 303.
https://doi.org/10.1182/blood.V112.11.303.303
Published: 2008
Journal Articles

Improved Outcome with Pulses of Vincristine and Steroids in Continuation Therapy of Children with Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC Randomized Phase III Trial 58951

Barbara De Moerloose, Stefan Suciu, Yves Bertrand, Francoise Mazingue, Alain Robert, Anne Uyttebroeck, Karima Yacouben, Alina Ferster, Geneviève Margueritte, Patrick Lutz, Martine Munzer, Nicolas Sirvent, Lucilia Norton, Patrick Boutard, Dominique Plantaz, Frédéric Millot, Pierre Philippet, Liliana Baila, Yves Benoit, Jacques Otten
Journal: Blood
Blood (2008) 112 (11): 11.
https://doi.org/10.1182/blood.V112.11.11.11
Published: 2008
Journal Articles

Results of a Phase II Trial Testing Interferon Alpha 2b and Cytarabine in Children with Chronic Myelogenous Leukemia.

Frédéric Millot, MD, Joelle Guilhot, BS, Brigitte Nelken, MD, Jean-Pierre Lamagnère, MD, Thierry Leblanc, MD, Guy Leverger, MD, Anne Notz, MD, Dominique Plantaz, MD, Frédéric Bernard, MD, Pierre Bordigoni, MD, Karima Yacouben, MD, Catherine Behar, MD, Antoine Thyss, MD, Cornu Guy, MD, Sylvain Duchène, MD, François Guilhot, MD
Journal: Blood
Blood (2004) 104 (11): 1000.
https://doi.org/10.1182/blood.V104.11.1000.1000
Published: 2004
Journal Articles

Ras Pathway Activation in Childhood B-Lineage Acute Lymphoblastic Leukemia: Ras , Ptpn11 , and Flt3 Mutations.

Hélène Cavé, Sami Saba, Nathalie Philippe, Nathalie Grardel, Brigitte Nelken, Lucilia Norton, Alain Robert, Karima Yacouben, Etienne Vilmer, Yves Bertrand, Claude Preudhomme
Journal: Blood
Blood (2004) 104 (11): 166.
https://doi.org/10.1182/blood.V104.11.166.166
Published: 2004